J.S. Brar

660 total citations
25 papers, 490 citations indexed

About

J.S. Brar is a scholar working on Psychiatry and Mental health, Clinical Psychology and Cognitive Neuroscience. According to data from OpenAlex, J.S. Brar has authored 25 papers receiving a total of 490 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Psychiatry and Mental health, 7 papers in Clinical Psychology and 6 papers in Cognitive Neuroscience. Recurrent topics in J.S. Brar's work include Schizophrenia research and treatment (5 papers), Tryptophan and brain disorders (4 papers) and Obsessive-Compulsive Spectrum Disorders (3 papers). J.S. Brar is often cited by papers focused on Schizophrenia research and treatment (5 papers), Tryptophan and brain disorders (4 papers) and Obsessive-Compulsive Spectrum Disorders (3 papers). J.S. Brar collaborates with scholars based in United States, Poland and India. J.S. Brar's co-authors include Rohan Ganguli, Martin Strassnig, V.L. Nimgaonkar, Vishwajit L. Nimgaonkar, K. N. Roy Chengappa, Bruce S. Rabin, Susan M. Sereika, Irene Kane, Aravinda Chakravarti and B. S. Rabin and has published in prestigious journals such as NeuroImage, Biological Psychiatry and Annals of the New York Academy of Sciences.

In The Last Decade

J.S. Brar

25 papers receiving 469 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.S. Brar United States 13 237 109 97 93 91 25 490
Odette Peerbooms Netherlands 8 186 0.8× 137 1.3× 68 0.7× 134 1.4× 52 0.6× 9 633
Po Wu Gean Taiwan 10 210 0.9× 46 0.4× 137 1.4× 56 0.6× 75 0.8× 11 528
Luciano K. Jornada Brazil 14 198 0.8× 31 0.3× 110 1.1× 50 0.5× 87 1.0× 27 502
Christoph Klawe Germany 13 132 0.6× 54 0.5× 49 0.5× 60 0.6× 218 2.4× 21 725
Tatjana Dose Germany 7 174 0.7× 61 0.6× 177 1.8× 22 0.2× 83 0.9× 10 658
Susan Simmons-Alling United States 12 151 0.6× 35 0.3× 92 0.9× 46 0.5× 209 2.3× 21 487
Karuna Jayathilake United States 17 537 2.3× 108 1.0× 95 1.0× 69 0.7× 218 2.4× 24 812
Ather Muneer Pakistan 11 304 1.3× 50 0.5× 218 2.2× 70 0.8× 43 0.5× 23 613
Yakup Albayrak Türkiye 15 169 0.7× 48 0.4× 89 0.9× 30 0.3× 61 0.7× 48 511
Neda Sharifi Iran 6 241 1.0× 138 1.3× 175 1.8× 49 0.5× 29 0.3× 14 541

Countries citing papers authored by J.S. Brar

Since Specialization
Citations

This map shows the geographic impact of J.S. Brar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.S. Brar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.S. Brar more than expected).

Fields of papers citing papers by J.S. Brar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.S. Brar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.S. Brar. The network helps show where J.S. Brar may publish in the future.

Co-authorship network of co-authors of J.S. Brar

This figure shows the co-authorship network connecting the top 25 collaborators of J.S. Brar. A scholar is included among the top collaborators of J.S. Brar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.S. Brar. J.S. Brar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Kane, Irene, et al.. (2011). Feasibility of pedometers for adults with schizophrenia: pilot study. Journal of Psychiatric and Mental Health Nursing. 19(1). 8–14. 22 indexed citations
3.
Ganguli, Rohan & J.S. Brar. (2011). Weight reduction in schizophrenia, by lifestyle change: a randomized clinical trial. Canadian Journal of Diabetes. 35(2). 153–153. 1 indexed citations
4.
Strassnig, Martin, J.S. Brar, & Rohan Ganguli. (2003). Nutritional Assessment of Patients With Schizophrenia: A Preliminary Study. Schizophrenia Bulletin. 29(2). 393–397. 139 indexed citations
5.
Ganguli, Rohan, Susan A. Berry, Georges M. Gharabawi, et al.. (2003). Randomized assessment of strategies for switching patients with sub-optimal treatment outcomes from olanzapine to risperidone. Schizophrenia Research. 60(1). 283–283. 2 indexed citations
6.
Brar, J.S., et al.. (2002). Can clinical features of bipolar-I disorder be assessed reliably on the telephone?. Journal of Affective Disorders. 71(1-3). 221–227. 4 indexed citations
7.
Nimgaonkar, Vishwajit L., Alan R. Sanders, Rohan Ganguli, et al.. (1996). Association study of schizophrenia and the dopamine D3 receptor gene locus in two independent samples. American Journal of Medical Genetics. 67(6). 505–514. 37 indexed citations
8.
Nimgaonkar, V.L., et al.. (1996). 5-HT2 receptor gene locus. Psychiatric Genetics. 6(1). 23–28. 41 indexed citations
9.
Nimgaonkar, Vishwajit L., et al.. (1995). Lack of association of schizophrenia with the neurotrophin‐3 gene locus. Acta Psychiatrica Scandinavica. 92(6). 464–466. 19 indexed citations
10.
Nimgaonkar, Vishwajit L., et al.. (1995). Association study of schizophrenia and the IL‐2 receptor β chain gene. American Journal of Medical Genetics. 60(5). 448–451. 13 indexed citations
11.
Cohen, Jonathan D., et al.. (1995). Hypofrontality and working memory dysfunction in schizophrenia. Biological Psychiatry. 37(9). 633–633. 4 indexed citations
12.
Brar, J.S., et al.. (1995). Reduced fertility in schizophrenia: Here to stay?. Schizophrenia Research. 15(1-2). 196–196. 1 indexed citations
13.
Chengappa, K. N. Roy, Galina V. Shurin, J.S. Brar, et al.. (1994). An association between anti-hippocampal antibody concentration and lymphocyte production of IL-2 in patients with schizophrenia. Psychological Medicine. 24(2). 449–455. 34 indexed citations
14.
Ganguli, Rohan, et al.. (1994). Effects of Hydrocortisone Infusion on rCBF in Schizophrenic Patients during a Memory Task. An O15 PET Studya. Annals of the New York Academy of Sciences. 746(1). 385–387. 2 indexed citations
15.
Ganguli, Rohan, et al.. (1994). rCBF (015 PET) during cognitive and physiological stimulation in schizophrenics. Biological Psychiatry. 35(9). 621–622. 1 indexed citations
16.
Nimgaonkar, Vishwajit L., et al.. (1993). Co‐occurrence of schizophrenia and Treacher Collins syndrome. American Journal of Medical Genetics. 48(3). 156–158. 5 indexed citations
17.
Ganguli, Rohan & J.S. Brar. (1992). Generalizability of First-Episode Studies in Schizophrenia. Schizophrenia Bulletin. 18(3). 463–469. 13 indexed citations
18.
Chengappa, K. N. Roy, A. Betts Carpenter, Zan Wei Yang, et al.. (1992). Elevated IGG anti-histone antibodies in a subgroup of medicated schizophrenic patients. Schizophrenia Research. 7(1). 49–54. 12 indexed citations
19.
Chengappa, K. N. Roy, Rohan Ganguli, Richard F. Ulrich, et al.. (1992). The prevalence of autoantibodies among right and left handed schizophrenic patients and control subjects. Biological Psychiatry. 32(9). 803–811. 11 indexed citations
20.
Chengappa, K. N. Roy, et al.. (1992). Left-handed first-episode, neuroleptic-naive schizophrenic patients have a higher prevalence of autoantibodies. Schizophrenia Research. 8(1). 75–80. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026